Phosphoramidite Market Report 2026

The phosphoramidite market size has grown strongly in recent years. It will grow from $1.07 billion in 2025 to $1.15 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to growth in DNA sequencing activities, expansion of academic research funding, increased use of synthetic nucleic acids, development of solid-phase synthesis techniques, rising demand for molecular diagnostics.

The phosphoramidite market size is expected to see strong growth in the next few years. It will grow to $1.5 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to expansion of RNA-based therapeutics, growth in gene editing technologies, increased pharmaceutical R&D investment, rising demand for custom oligonucleotides, scaling of automated synthesis platforms. Major trends in the forecast period include rising demand for oligonucleotide synthesis materials, expansion of gene therapy and RNA therapeutics, increasing use in diagnostic and research applications, growing adoption of automated solid-phase synthesis, increased focus on high-purity chemical inputs.

The growth of the biopharmaceutical sector is expected to drive the demand for the phosphoramidite market in the coming years. The biopharmaceutical sector encompasses the industry engaged in the research, development, production, and commercialization of medical products derived from biological sources, including vaccines, gene therapies, monoclonal antibodies, and recombinant proteins. The sector’s expansion is fueled by advancements in biotechnology, the rising prevalence of chronic diseases, and increased investments in research and development. Innovations in biotechnology, such as gene editing and monoclonal antibody therapies, have enabled the development of more effective and targeted treatments. For example, in October 2025, the Office for National Statistics, a UK-based government agency, reported that in 2024, the UK life sciences industry included 6,170 businesses operating across 7,320 sites, employing 359,600 people, and generating $191 billion (£146.9 billion) in revenue. The largest subsector in terms of both company count and workforce was medical technology, accounting for 60% of all companies and 55% of total employment. As a result, the growth of the biopharmaceutical sector is contributing to the expansion of the phosphoramidite market.

Major companies operating in the phosphoramidite market are concentrating on advancing DNA synthesis, including methods such as convertible-preferred stock financing, to support the adoption and development of Gibson SOLA technology for rapid DNA and mRNA synthesis. Convertible-preferred stock financing is a strategy for raising capital where a company issues preferred shares that can later be converted into a specified number of common shares. For example, in March 2025, Telesis Bio Inc., a US-based biotechnology firm, announced securing up to $21 million in new funding to accelerate the commercialization of its next-generation enzymatic DNA synthesis platform, Gibson SOLA, with backing from multiple strategic investors. This financing is intended to scale the company’s fully enzymatic DNA synthesis technology, expand its R&D and manufacturing capabilities, and increase access to rapid, customizable long-DNA production. The company employs a proprietary enzymatic method that allows fast and precise synthesis of long DNA sequences, overcoming current limitations of traditional phosphoramidite-based approaches.

In May 2023, Actylis, a US-based chemicals and raw materials company, formed a partnership with Innovassynth India to tackle vulnerabilities in the nucleic acid supply chain. Through this collaboration, Innovassynth and Actylis aim to reinforce the phosphoramidite market by providing a stable, transparent, and diversified supply chain, enhancing global access to premium nucleosides and phosphoramidites for pharmaceutical and biotech uses. Innovassynth India is an India-based producer of protected nucleosides, phosphoramidites, and reagents.

Major companies operating in the phosphoramidite market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Aragen Life Sciences, Twist Bioscience, Innovassynth Technologies (I) Ltd., Tokyo Chemical Industry Co. Ltd. (TCI), Aurigene Services, Eurofins Genomics, LGC Biosearch Technologies, Link Technologies Ltd., Creative Biolabs, Biosynth Carbosynth, TriLink BioTechnologies, ChemGenes Corporation, Berry & Associates Inc., Lumiprobe Corporation, Hongene Biotech Corporation, Carbolink India Pvt. Ltd., PolyOrg Inc., Glen Research, Gene Link Inc., emp BIOTECH GmbH.

North America was the largest region in the phosphoramidite market in 2025. Europe is expected to be the fastest-growing region during the forecast period. The regions covered in the phosphoramidite market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the phosphoramidite market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have affected the phosphoramidite market by increasing the cost of imported specialty chemicals, intermediates, and high-purity reagents used in oligonucleotide synthesis. These impacts have been most pronounced in pharmaceutical and biotechnology application segments, particularly in north america and europe where raw material sourcing is globally diversified. Asia-pacific manufacturers have faced procurement delays and pricing pressure. However, tariffs have encouraged localized chemical manufacturing and regional supplier development, supporting supply reliability.

The phosphoramidite market research report is one of a series of new reports that provides phosphoramidite market statistics, including phosphoramidite industry global market size, regional shares, competitors with a phosphoramidite market share, detailed phosphoramidite market segments, market trends and opportunities, and any further data you may need to thrive in the phosphoramidite industry. This phosphoramidite market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Phosphoramidite is a chemical compound frequently employed in the synthesis of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) via solid-phase synthesis. It contains a phosphate group connected to an amine (-NR₂) and exhibits high reactivity, enabling the stepwise addition of nucleotide bases during oligonucleotide synthesis. Phosphoramidites play a vital role in generating synthetic nucleic acids for research, diagnostic, and therapeutic purposes.

The main types of phosphoramidites include deoxyribonucleic acid (DNA) phosphoramidites, ribonucleic acid (RNA) phosphoramidites, labeled phosphoramidites, modifier phosphoramidites, and others. DNA phosphoramidites serve as chemical building blocks in solid-phase DNA synthesis, enabling the creation of custom sequences for applications such as gene synthesis, PCR, and molecular diagnostics. They offer various synthesis methods, including the h-phosphonate method, phosphoramidite method, and trivalent phosphorus compounds method, which are applied in gene synthesis, DNA sequencing, and DNA amplification. These phosphoramidites are utilized by a range of end-users, including academic research institutions, the pharmaceutical industry, and the biotechnology sector.

The phosphoramidite market consists of sales of spacer and linker phosphoramidites, fluorescent dye-Labeled phosphoramidites, biotinylated phosphoramidites, and structural phosphoramidites. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.